Suchergebnisse - "Fajgenbaum, David C"

PubPharm (7)

1

How we manage idiopathic multicentric Castleman disease

enthalten in: Clinical advances in hematology & oncology : H&O | 2022

von Brandstadter, J. | Fajgenbaum, D.

2

Effectiveness of rituximab-containing treatment regimens in idiopathic multicentric Castleman disease

enthalten in: Annals of hematology | 2018

von Dong, Y. | Zhang, L. | Nong, L. | +6

3

International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease

enthalten in: Blood | 2017

von Fajgenbaum, D. | Uldrick, T. | Bagg, A. | +35

4

Potential value of FDG PET-CT in diagnosis and follow-up of TAFRO syndrome

enthalten in: Annals of hematology | 2016

von Behnia, F. | Elojeimy, S. | Matesan, M. | +1

5

Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV‐8‐negative multicentric Castleman disease

enthalten in: American journal of hematology | 2016

von Moro, H. | Kondo, E. | Nakamura, N. | +19

6

A Rare Disease That Picked the Wrong Family: Fighting Back to Help a Loved One and as a Tool for Actively Coping

enthalten in: Death studies | 2015

von Fajgenbaum, D.

7

HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy

enthalten in: Blood | 2014

von Fajgenbaum, D. | van Rhee, F. | Nabel, C.

1
[1]